Smartphone diagnostic specialist Novarum™ DX has achieved a significant milestone in the development of its revolutionary technology after being officially granted a European patent. Novarum has been awarded the patent (EP 12718728.4) for its smartphone diagnostic technology by the European Patent Office (EPO), having already secured the equivalent patent for its technology in the United…

A leading biotechnology company has developed a rapid test to measure recombinant lentivirus titers using a smartphone as a diagnostic reader. Takara Bio USA, Inc. (TBUSA; formerly Clontech Laboratories, Inc.) teamed up with smartphone diagnostics specialists, Novarum™ DX, to develop an integrated, mobile platform which detects and quantifies recombinant lentivirus in packaging cell supernatants. Novarum’s…

Late last year the FDA cleared a pill with an inbuilt ingestion tracking system. Remarkably, the tablets have an inbuilt sensor that is aware when the medication has been taken and data is transmitted to a patch worn outside the body. This lets clinicians know whether patients have been taking the prescribed dose of medication…

A smartphone diagnostic specialist has been accredited with ISO 13485:2016 certification for Medical Device Quality Management Systems (QMS). Novarum™ DX transitioned from ISO 13485:2003, the internationally recognised Medical Device Quality Management System standard, to the new ISO 13485:2016 standard with zero non-conformances, ahead of the transition deadline in March 2019. To achieve certification, Novarum embarked…

Novarum™ DX has been officially granted a patent for their revolutionary smartphone diagnostic technology in the United States. Part of BBI Solutions, Novarum has developed image capture technology which transforms a smartphone into a diagnostic reader to deliver accurate test results, of lab-quality, directly from the point of care. The US patent (9,903,857) was officially…